Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inward rectification and implications for cardiac excitability

C G Nichols1, E N Makhina, W L Pearson

  • 1Department of Cell Biology and Physiology, Washington University School of Medicine, St Louis, Mo 63110, USA.

Circulation Research
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson in the bb[over ¯] Final State Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36  TeV with the ATLAS Detector at the LHC.

Physical review letters·2025

Inwardly rectifying potassium channels in the heart are crucial for cardiac excitability. Polyamines and Mg2+ ions block these channels, influencing heart function and offering potential pharmacological targets.

Area of Science:

  • Molecular Biology
  • Cardiovascular Physiology
  • Ion Channel Function

Background:

  • Since 1993, multiple inwardly rectifying potassium (Kir) channel clones have been identified, with significant expression in the heart.
  • These cloned channels exhibit functional properties of classic inward rectifier, ATP-sensitive K+, and muscarinic receptor-activated channels.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying anomalous rectification in cardiac Kir channels.
  • To explore the structural and functional roles of polyamines and Mg2+ in Kir channel activity.
  • To assess the implications for understanding and pharmacologically modulating cardiac excitability.

Main Methods:

  • High-level expression of cloned cardiac Kir channels.
  • Electrophysiological studies to analyze channel rectification properties.

Related Experiment Videos

  • Site-directed mutagenesis to investigate structural requirements for rectification.
  • Computational simulations to predict effects of altered polyamine concentrations.

    • Main Results:

    • Anomalous rectification is primarily caused by steeply voltage-dependent block by polyamines, with a contribution from Mg2+ ions.
    • Primary structures of Kir channels and mutagenesis studies have identified key structural determinants of rectification.
    • Polyamines and Mg2+ block are critical for the characteristic current-voltage relationship of these channels.

    Conclusions:

    • Understanding Kir channel structure and block mechanisms provides fundamental insights into cardiac electrical activity.
    • Cellular polyamine concentrations can be altered and pharmacologically manipulated, potentially impacting cardiac excitability.
    • Modulation of polyamine levels or species offers a promising avenue for pharmacological interventions targeting cardiac function.